LANGALI GUTIKA AND DHATURADYA TAILA TREATMENT IN VATARAKTA(Gout).

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF LANGALI GUTIKA AND DHATURADYA TAILA IN THE MANAGEMENT OF VATARAKTA - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/081209

Enrollment

Registered

2025-02-24

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M206- Acquired deformities of toe(s), unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with classical sign & symptoms of Vatarakta and Uric acid level more than 7mg/dl for male and 6mg/dl for female. 2.Patients between the ages of 20 years to 60 years.

Exclusion criteria

Exclusion criteria: 1. Age below 20 years and above 60 years. 2. Patient associated with any other systemic disease e.g., Diabetes, Hypertension, Severe cardiac disease etc. 3. Pregnancy and lactating mother. 4. Patient without written consent form. 5. Female patient with PCOD and heavy Bleeding in Menses. 6. Patient presenting with tophi, cellulitis, renal and liver disorder, bone deformities, rheumatoid arthritis and Osteoarthritis.

Design outcomes

Primary

Measure	Time frame
It is expected that at the end of study we would be able to demonstrate the efficacy of Langali Gutika and Dhaturadya Taila in the management of VataraktaTimepoint: NIL	—

Secondary

Measure	Time frame
At the end of study we would be able to demonstrate the efficacy of Langali Gutika And Dhaturadya Taila in the management of VataraktaTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Jagrati Ahirwar

Pt. Khushilal Sharma Govt. (Auto) Ayurveda College and Institute Bhopal mp.

deepika.smiling@gmail.com8143449578

Outcome results